Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
Margherita Brindisi(University of Naples Federico II), Giuseppe Campiani(University of Siena), A. Prasanth Saraswati(University of Siena), Stefania Butini(University of Siena), Simone Brogi(University of Pisa), Sandra Gemma(University of Siena)
Cited by 115
Related Papers
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent
|Journal of Medicinal Chemistry|2001|94